Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026 Lead Investing
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026 Lead Investing
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer Lead Investing
Silver X Expands Red Silver Drill Program More Than Five-Fold to 6,650 Meters Following High-Grade Channel Sampling Results Lead Investing
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 Lead Investing
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery ) Program Data and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference 2026 Lead Investing
